Mr. Speaker, I am pleased to rise today to talk about Bill C-13.
My party has a lot of concerns about Bill C-13. My colleague from Nanaimo—Alberni has pointed out a lot of concerns and why our party would not support the use of embryonic stem cells in research. He has pointed out the alternatives and the medical scientific breakthroughs that have been made in adult stem cell research.
I want to mention some more concerns that we have. First, there are some things in the bill that we do agree with. For example, the bill does point out that the health and well-being of children born through assisted human reproduction must be given priority. We certainly would support that.
We support the bans on reproductive or therapeutic cloning, chimeras, animal-human hybrids, sex selection, germ line alteration, the buying or selling of embryos and paid surrogacy.
We support an agency to regulate the sector, although we want changes to it that we believe are necessary.
There has probably not been a bill put to this House in the last several years that has caused me to receive more mail in my office than the issue of stem cell research. I can say that the citizens of Prince George—Bulkley Valley have overwhelmingly expressed their opposition to embryonic research over the past several months and have asked me to speak on their behalf in the House of Commons.
Embryonic research is a very ethically controversial proposal and type of medical research. It is dividing Canadians. We have witnessed that in the House with the different views of members of Parliament supposedly speaking on behalf of their ridings. We have seen the numerous petitions that have been tabled in the House calling for ethical stem cell research.
It has been pointed out by my colleagues and in petitions that embryonic stem cell research inevitably results in the death of the embryo, which is the death of early human life. For many Canadians, this practice would violate the ethical commitment to respect human dignity, integrity and life.
There is an incontestable scientific fact that supports the statement that an embryo is early human life. It states that the complete DNA of an adult human is present at the embryonic stage. Whether that life is owed protection is one of the issues we want to talk about today and one of the issues that should be present in this entire debate.
Embryonic research also constitutes an objectification of human life where human life in a way can become a tool that can be manipulated and destroyed for other ethical ends. Adult stem cells, on the other hand, are a safe, proven alternative to embryonic stem cells. My colleague from Nanaimo on Vancouver Island has spoken about that at length.
There are innumerable sources of adult stem cells such as skin tissue, bone tissue, and umbilical cord blood. There is no shortage of a source for adult stem cells. We must question why some in Parliament and some in the medical community appear so determined to pursue embryonic stem cell research when adult stem cells are so readily accessible and have been proven to be beneficial in research.
Adult stem cells are not subject to immune rejection and pose minimal ethical concerns. Embryonic stem cell transplants are subject to immune rejection because they are foreign tissue. Adult stem cells used for transplants typically are taken from one's own body.
Adult stem cells are being used today in the treatment of Parkinson's disease, leukemia, MS and many other conditions, and are working very well in that type of treatment. Conversely I must point out that embryonic stem cells have not been used in the successful treatment of a single person. Given a lot of these facts, one must wonder why this drive to get into embryonic stem cell research is so ongoing.
In our minority report from the health committee we called for a three year prohibition on experiments with human embryos corresponding with the first scheduled review of the bill. It should be pointed out that the government disregarded many of the points that were made in the health committee in order to put forward Bill C-13.
When we look at the bill we see many things that were left out. Amendments pertaining to the regulatory agency have not been included in Bill C-13. The health committee recommended many things like an end to donor anonymity. That has been left out of the bill. Our minority report said that where the privacy rights of the donors of human reproductive materials conflict with the rights of children to know their genetic and social heritage, the rights of the children should prevail. That was not included in the bill. When the issue came up during the review, the Liberals defeated our amendment to end anonymity in a six to five vote, so there was a split among the government members.
The bill supposes to support the health and well-being of children born through assisted human reproduction and that must be given a priority. We do support that. We support continued research using adult stem cells in medical research and treatment, as we have seen it being successful now.
However, our party cannot support Bill C-13 as it stands. We have amendments that we will be putting forward at different stages of the bill and we trust that the Liberals and the other members of the House will see the wisdom in our amendments and support them.